the response matrices measured for a number of samples is often
unique. If a unique decomposition is achieved, the second-order
advantage can be obtained, allowing a robust estimation of analyte
concentrations in mixtures, even in the presence of unknown
interferences.
zoic acid,26 and therefore, the simultaneous determination of both
compounds is important in monitoring fair horse sports. Several
analytical methods for the determination of either procaine or
p-aminobenzoic acid in a variety of samples are known;27-35
however, only few methods were developed for the simultaneous
determination of both compounds, mainly based on high-
performance liquid chromatographic techniques.36-38
In this report, we follow the hydrolysis of procaine to give
strongly fluorescent p-aminobenzoic acid in aqueous alkaline
media,39 by recording fluorescence excitation-emission matrices
as a function of reaction time, using a fast scanning detector, and
processing the obtained four-way information with the classical
PARAFAC model, as well as with the presently introduced
multiway latent structured method N-PLS/RTL and some of its
unfolded predecessors. We also compare the advantages and
disadvantages of the above-mentioned chemometric techniques
as regards the resolution of the presently studied multicomponent
mixtures.
Recently, alternatives based on data unfolding, such as trilinear
least-squares (TLLS)15 and unfolded-partial least-squares (U-PLS),16
have been introduced, which deal with this information by
concatenating (or unfolding) the original data into unidimensional
arrays (vectors). In the presence of unexpected compounds of
unknown origin, both of these methods should be complemented
with an additional procedure to achieve the second-order advan-
tage. A technique that is useful in this regard, called residual
trilinearization (RTL), has been developed by our group as an
extension of residual bilinearization (RBL),17,18 which was origi-
nally proposed for second-order data.15 Latent structured methods
such as U-PLS/RBL are particularly interesting, especially because
recent applications in the second-order domain have highlighted
its abilities in modeling nontrilinear data sets, when compared to
the more classical PARAFAC and bilinear least-squares/RBL
(BLLS/RBL) methods.19-21
However, it appears that a genuine multiway latent variable
method capable of achieving the second-order advantage is still
needed. We have recently combined multiway PLS (N-PLS)22 with
RBL for three-way data, producing a technique that is still under
testing in our laboratories, using both simulated and experimental
second-order data sets. In the present report, where four-way
kinetic fluorescence excitation-emission data are analyzed, we
introduce the required combination of N-PLS with RTL for third-
order data sets, extending the approach one further dimension.
The aim is the simultaneous quantitation of the anaesthetic
procaine and its metabolite p-aminobenzoic acid in equine serum
samples, where the background interference makes the use of
the second-order advantage mandatory.
THEORY
General Considerations. Before discussing specific aspects
of the employed algorithms, it is useful to consider the different
manners in which they process four-way data arrays. For a given
test or problem sample, PARAFAC builds a joined model, which
includes the third-order signals for all the calibration samples and
the analyzed test sample data. This must be done for each of the
test samples. In the first step of PARAFAC processing, the four-
way signal array is decomposed, while the calibration concentra-
tions are employed, in a subsequent step, to estimate a given
component concentration in the test sample. This means that a
new PARAFAC model is calculated for each new test or problem
sample to be predicted.
On the other hand, in the N-PLS/RTL, U-PLS/RTL, and TLLS/
RTL methodologies, the first step consists of establishing a
relationship between the measured calibration signals and the
known calibration concentrations, without considering the test
sample data. Once this is done, a postcalibration RTL procedure
applied to the test sample signals is introduced, allowing one to
model the presence of unexpected components and to accurately
estimate the analyte concentration.
Procaine (PRO, 2-diethylaminoethyl p-aminobenzoate hydro-
chloride) is used as a local anaesthetic. In human plasma, it is
almost completely hydrolyzed by the enzyme pseudocholinest-
erase to p-aminobenzoic acid (PAB) and diethylaminoethanol.23
The latter compound has both circulatory and neurological effects,
producing blood vessel constriction and euphoria.24 Procaine is
usually used in horses as an anaesthetic and a stimulating drug,
and also accompanying penicillin to treat infections, with plasma
In this way, PARAFAC resolves each component information
separately, and this is the reason why this model inherently
(26) Committee for Veterinary Medicinal Products, Procaine. Summary Report
EMEA/MRL/217/97-FINAL of the Veterinary Medicines Evaluation Unit,
European Agency for the Evaluation of Medicine Products, January 1998.
(27) Storms, M. L.; Stewart, J. T. J. Pharm. Biomed. Anal. 2002, 30, 49-58.
(28) Berzas Nevado, J. J.; Murillo Pulgar´ın, J. A.; Reillo Escudero, O. I. Appl.
Spectrosc. 2000, 54, 1678-1683.
concentrations on the order of 10 mg mL .
-1 25 Horse plasma does
not promote the complete hydrolysis of procaine into p-aminoben-
(15) Arancibia, J. A.; Olivieri, A. C.; Bohoyo Gil, D.; Mun˜oz de la Pen˜a, A.; Dura´n-
Mera´s, I.; Espinosa Mansilla, A. Chemom. Intell. Lab. Syst. 2006, 80, 77-
86.
(29) Einosuke, T.; Yuji, N.; Xuan, Z. S.; Shogo, M.; Yukio, K. Jpn. J. Forensic
Toxicol. 1995, 13, 11-16.
(16) Wold, S.; Geladi, P.; Esbensen, K.; O¨ hman, J. J. Chemom. 1987, 1, 41-56.
(17) O¨ hman, J.; Geladi, P.; Wold, S. J. Chemometrics 1990, 4, 79-90.
(18) Olivieri, A. C. J. Chemom. 2005, 19, 253-265.
(30) Carretero, A. S.; Cruces-Blanco, C.; Peinado, S. F.; Bergmi, R. E. I.; Gutie´rrez,
A. F. J. Pharm. Biomed. Anal. 1999, 21, 969-974.
(31) Badea, I.; Moja, D.; Vladescu, L. Anal. Biochem. 2002, 374, 51-53.
(32) Vanquerp, V.; Rodriguez, C.; Coiffard, C.; Coiffard, L. J. M.; De Roeck-
Holtzhauer, Y. J. Chromatogr., A 1999, 832, 273-277.
(19) Bohoyo Gil, D.; Mun˜oz de la Pen˜a, A.; Arancibia, J. A.; Escandar, G. M.;
Olivieri, A. C. Anal. Chem. 2006, 78, 8051-8058.
(20) Culzoni, M. J.; Goicoechea, H. C.; Pagani, A. P.; Cabezo´n, M. A.; Olivieri,
A. C. Analyst 2006, 131, 718-732.
(21) Garc´ıa-Reiriz, A.; Damiani, P. C.; Olivieri, A. C. Talanta 2007, 71, 806-815.
(22) Bro, R. J. Chemom. 1996, 10, 47-61.
(33) Kastel, R.; Rosival, I.; Blahovec, J. Biomed. Chromatogr. 1994, 8, 294-296.
(34) Stokes, D. L.; Vo-Dinh, T. Sens. Actuators, B 2000, 69, 28-36.
(35) Chen, L. C.; Hu, M. L. J. Food Drug Anal. 1996, 4, 75-87.
(36) Yang, H.; Thyrion, F. C. J. Liq. Chromatogr. Rel. Technol. 1998, 21, 1347-
1357.
(23) Reynolds, J. E. F., Ed. W. Martindale, Extra Pharmacopoeia, Pharmaceutical
Press: London, 1996; Vol. XXXI, p 76.
(24) Turner, P.; Volans, G.; Wiserman, H. Drugs Handbook; McMillan: London,
1993; p 76.
(37) Rop, P. P.; Grimaldi, F.; Bresson, M.; Fornaris, M.; Viala, A. J. Liq.
Chromatogr. 1993, 16, 2797-2811.
(38) Dhananjeyan, M. R.; Bykowski, C.; Trendel, J. A.; Sarver, J. G.; Andob, H.;
(25) Olse´n, L.; Ingvast-Larsson, C.; Brostro¨m, H.; Larsson, P.; Tj¨alve, H. J. Vet.
Pharmacol. Therap. 2007, 30, 201-207.
Erhardt, P. W. J. Chromatogr., B 2007, 847, 224-230.
(39) Kondritzer, A. A.; Zvirblis, P. J. Am. Pharm. Assoc. 1957, 46, 531-535.
6950 Analytical Chemistry, Vol. 79, No. 18, September 15, 2007